摘要 |
<p>A compound of Formula (I)
<Chemistry id="chema01" num="0001"><Image id="ia01" he="20" wi="44" file="IMGA0001.TIF" imgContent="chem" imgFormat="TIFF" /></Chemistry>
or
an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein A is independently selected from:
<Chemistry id="chema02" num="0002"><Image id="ia02" he="39" wi="117" file="IMGA0002.TIF" imgContent="chem" imgFormat="TIFF" /></Chemistry>
further wherein R<Sup>1</Sup>, R<Sup>2</Sup>, R<Sup>3</Sup>, R<Sup>4</Sup>, R<Sup>5</Sup>, R<Sup>6</Sup>, R<Sup>7</Sup>, and W are as described herein.</p><p>Also disclosed are pharmaceutical compositions containing compounds of Formula (I), and the use of said compounds for treating conditions associated with the activity of p38 kinase.</p> |